Les Entreprises du Médicament publient leur 6ème rapport de responsabilité sociétale Espace presse Depuis 2005, Les Entreprises du Médicament conduisent une démarche collective sur les enjeux de responsabilité sociétale sur lesquels elles sont sollicitées. Chaque année, elles dressent le bilan des actions et des travaux menés au travers d’un rapport public. Pour la première fois, ce rapport RSE renseigne les indicateurs issus de la Convention de progrès des Entreprises du Médicament dans le cadre du Grenelle de l’environnement. L’année 2010 a été marquée sur le plan environnemental par la mise à disposition des entreprises de CarbonEM®, un outil de mesure des émissions de gaz à effet de serre propre au secteur pharmaceutique et la publication d’un manuel sur l’éco-conception des emballages de médicaments. En matière sociale, le Leem a multiplié les actions pour développer les compétences et la mobilité professionnelles des salariés dans un contexte de forte mutation du secteur.
Core Fulbright Scholar Program | Awards Catalog | Application Form I anticipate that after my research in [host country], I will be in a strong position to begin writing a monograph that focuses on women’s education and their scholarly networks in medieval Syria, which is the ultimate goal of my research. Such a publication will be of interest not only to scholars of medieval Islam and women’s studies but also to those who are interested in understanding the historical contexts of Muslim educational systems. Further, I expect that this study can contribute to future work in the field of comparative religions as there are a number of intriguing parallels between medieval Muslim female scholars and their Christian counterparts in Western Europe. As a Fulbright Research Fellow, I aim not only to contribute to the fields of gender studies and Muslim social history, but also to demonstrate the tremendous potential of archival research on women in countries such as Syria. Prof. The impact of a Fulbright award for my home institution would be significant.
Pharmaceutical Market Trends 2010-2011, Pharma Market Forecasting, Pharmaceutical Industry Trends The global pharmaceutical market research has been done by many companies and almost all of the market reports indicate a significant growth of pharma market in 2010-2011. The forecasting indicates pharmaceutical market growth of about 4 - 6% in 2010-2011. The established markets, including the US, UK, and Japan, together account for 30% of the global demand for pharmaceutical excipients. Pharmaceutical Industry Trends- Global Scenario If present industry overview is taken into consideration then the global pharmaceutical market in 2010 is projected to grow 4 - 6% exceeding $825 billion. Asia Pacific Pharmaceutical Market The pharma market world over will experience significant shifts. Middle East Pharmaceutical Market The Middle East combined with the African Pharmaceutical market is projected to grow at a CAGR of around 11% during 2010-2012. Pharmaceutical Drugs Trends Anti-Diabetic Drugs and those for cardiovascular diseases are expected to see the fastest growth in 2011.
Grants and Awards Resources Finding Funds some links to external resources of interest for geography and related fields General Directories Chronicle of Philanthropy The Foundation Center AAAS Science Magazine's GrantsNet sciencecareers.sciencemag.org/funding Financial Aid GuideOnlineSchools.org Guide to Financial Aid www.onlineschools.org/financial-aid/ Foundations Alfred P. Fellowships American Geographical Society Library Short-term Fellowships www4.uwm.edu/libraries/AGSL/fellowships.cfm American Geographical Society Council Fellowships Proposal Writing Basics Chapter 11, Preparing Competitive Research Grant Proposals, Aspiring Academics (2009 www.aag.org/cs/education/edge/books The Foundation Center’s Proposal Writing Short Course Advice for Graduate Students from About.com
Ten-Year Data on Pharmaceutical Mergers and Acquisitions, from DealSearchOnline.com, Reveals Top Deals and Key Companies Ten-Year Data on Pharmaceutical Mergers and Acquisitions, from DealSearchOnline.com, Reveals Top Deals and Key Companies NORWALK, Conn., Mar 25, 2010 (BUSINESS WIRE) -- During the 10 years ended December 31, 2009, a total of 1,345 mergers and acquisitions of pharmaceutical assets and pharmaceutical companies were announced, with disclosed prices totaling more than $694 billion, according to DealSearchOnline.com. GlaxoSmithKline was responsible for the largest of the pharmaceutical mergers and acquisitions this past decade: GlaxoWellcome announced a $74 billion merger with SmithKline Beecham in 2000, resulting in the entity now known as GlaxoSmithKline. Pfizer, Inc. announced two of the largest pharmaceutical mergers and acquisitions of the decade, including its $68 billion acquisition of Wyeth, Inc. in 2009 and its $56 billion acquisition of Pharmacia Corporation in 2002. * To receive this press release via email, send a message to email@example.com
Home | AAG Pharma 2020: The vision: Which path will you take? Which path will you take? By 2020 the pharmaceutical market is anticipated to more than double to US$1.3 trillion, with the E7 countries — Brazil, China, India, Indonesia, Mexico, Russia and Turkey — accounting around for one fifth of global pharmaceutical sales. Further, incidence of chronic conditions in the developing world will increasingly resemble those of the developed world. Pharma 2020: The vision: Which path will you take? indicates that the current pharmaceutical industry business model is both economically unsustainable and operationally incapable of acting quickly enough to produce the types of innovative treatments demanded by global markets. Some of the major changes PwC anticipates for the industry are: Health care will shift in focus from treatment to prevention. More information Pharma 2020: Taxing times ahead, the fifth in the series focuses on the industry's opportunities and challenges from a tax perspective.
GCSE Bitesize - Geography Pharmaceutical industry The pharmaceutical industry develops, produces, and markets drugs or pharmaceuticals licensed for use as medications. Pharmaceutical companies are allowed to deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations regarding the patenting, testing and ensuring safety and efficacy and marketing of drugs. History The earliest drugstores date to the Middle Ages. The first known drugstore was opened by Arabian pharmacists in Baghdad in 754, and many more soon began operating throughout the medieval Islamic world and eventually medieval Europe. Most of today's major pharmaceutical companies were founded in the late 19th and early 20th centuries. Legislation was enacted to test and approve drugs and to require appropriate labeling. Numerous new drugs were developed during the 1950s and mass-produced and marketed through the 1960s. Cancer drugs were a feature of the 1970s. Marketing changed dramatically in the 1990s.
Fellowships and Assistantships | The Graduate School For more information, click on any of the fellowships below. Or, to view fellowship by deadline date, click on any of the months to reveal fellowships with deadlines in that month. American Association of University Women (AAUW) American Fellowships support women doctoral candidates completing dissertations or scholars seeking funds for postdoctoral research leave from accredited institutions. Deadline: November 15, 2013, 3:00 pm (PST) Eligibility Requirements: Applicants must be U.S. citizens or permanent residents. For information and applications: please to the AAUW website. American Association of University Women (AAUW) Career Development Grants provide support for women in pursuing additional education. Deadline: December 15, 2013, 3:00 p.m. Eligibility Requirements: Women who hold a bachelor's degree and are preparing to advance their careers, change careers, or re-enter the work force. For information and applications: please go to the AAUW website. Architecture (M.Arch., M.S.
Pharma Analytics | Pharmaceutical Analysis | Pharma Industry Analysis Pharmaceutical companies are under increasing pressure to change their business model to deal with the reduction of the drug pipeline and increasing competition from generic drugs. They would need to better manage and exploit existing products throughout their entire life cycle. They must also address the needs of the increasing number of stakeholders who influence patients’ access to medicine. Most common challenges faced by pharmaceutical companies are: Identify best market to penetrate Where to target promotional campaigns, promotional ROI analysis Competitor analysis Understand factors that drive sales Sales forecasting indicators Maximize product and market performance Effective product, channels and sales strategy development Measure promotional response Hexaware, with its range of Pharma Analytics and Reports covers a number of market dimensions such as Brand Positioning, Competitor Analysis, Competitor Positioning, Market Share, etc. Few of the key factors for Analysis are:
Digital map. Gough Map. [Image: Fragment of the Gough Map] Linguistic Geographies: The Gough Map of Great Britain Digital Map Hide Gough Map features ‹‹ First ‹ Previous 1 Next › Last ›› © 2011 King's College London